Patents by Inventor Michael Hawkins

Michael Hawkins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12301525
    Abstract: In some aspects, the techniques described herein relate to a method including: initiating a communication session between a user and an agent; generating an application link for the communication session, the application link associated with a co-browsing application; transmitting the application link to a client device associated with the user; receiving data from the client device via the co-browsing application executed in response to the application link and associating the data with the communication session; pre-populating a co-browsing session using the data; and synchronizing a display of pages between an agent emulator and the co-browsing application, wherein synchronizing includes rendering a given page on both the agent emulator and the co-browsing application and displaying an input received via the co-browsing application in the agent emulator.
    Type: Grant
    Filed: May 24, 2023
    Date of Patent: May 13, 2025
    Assignee: Verizon Patent and Licensing Inc.
    Inventors: Hussair Kaja, Anand Ashok Mirji, Aaron Bittig, Michael Hawkins
  • Patent number: 12265591
    Abstract: Enhanced metadata with optimized output. In an embodiment, a content object is received. First metadata to be associated with the content object is determined. At least one metadata field to be acquired is determined based on an association, within a stored knowledge structure, of the at least one metadata field with the first metadata. Second metadata to be associated with the content object is acquired based on the at least one metadata field. A metadata structure and markup format for the content object are determined. The metadata structure incorporates both the first metadata and the second metadata. The content object is output with the metadata structure and in the markup format.
    Type: Grant
    Filed: September 25, 2023
    Date of Patent: April 1, 2025
    Assignee: Einstein Industries, Inc.
    Inventors: Robert Silkey, Ted Ricasa, Sergiy Zubatiy, Jeremy Michael Hawkins, Christopher Cherry
  • Publication number: 20240241147
    Abstract: A laboratory system includes: at least one reactor; a sample extraction device for extracting a sample from the at least one reactor into a sampling space; a fluid supply system including a transportation fluid supply; at least one sample storage container; at least one fluid supply channel connecting the extraction device to the fluid supply system; at least one sample extraction channel connecting the extraction device to the sample storage container, where the fluid supply system is arranged to push the sample from the sampling space through the sample extraction channel to the at least one sample storage container using transportation fluid of the transportation fluid supply.
    Type: Application
    Filed: April 14, 2022
    Publication date: July 18, 2024
    Inventors: Stephan Olivier van Banning, Serge Peter Sonneborn, David Michael Pfisterer, Joel Michael Hawkins
  • Patent number: 11768910
    Abstract: Enhanced metadata with optimized output. In an embodiment, a content object is received. First metadata to be associated with the content object is determined. At least one metadata field to be acquired is determined based on an association, within a stored knowledge structure, of the at least one metadata field with the first metadata. Second metadata to be associated with the content object is acquired based on the at least one metadata field. A metadata structure and markup format for the content object are determined. The metadata structure incorporates both the first metadata and the second metadata. The content object is output with the metadata structure and in the markup format.
    Type: Grant
    Filed: August 27, 2021
    Date of Patent: September 26, 2023
    Assignee: EINSTEIN INDUSTRIES, INC.
    Inventors: Robert Silkey, Ted Ricasa, Sergiy Zubatiy, Jeremy Michael Hawkins, Christopher Cherry
  • Publication number: 20230174539
    Abstract: The disclosure is directed to compounds of Formula (I) and Formula (II), Formula (I) and Formula (II) and pharmaceutically acceptable salts or solvates thereof. Pharmaceutical compositions comprising compounds of Formula (I) or Formula (II), as well as methods of their use and preparation, are also described.
    Type: Application
    Filed: December 12, 2022
    Publication date: June 8, 2023
    Inventors: Hong Lin, Michael Hawkins, Juan Luengo
  • Patent number: 11524962
    Abstract: The disclosure is directed to compounds of Formula (I) and Formula (II). Formula (I) and Formula (II) and pharmaceutically acceptable salts or solvates thereof. Pharmaceutical compositions comprising compounds of Formula (I) or Formula (II), as well as methods of their use and preparation, are also described.
    Type: Grant
    Filed: October 26, 2018
    Date of Patent: December 13, 2022
    Assignee: Prelude Therapeutics, Incorporated
    Inventors: Juan Luengo, Hong Lin, Michael Hawkins
  • Publication number: 20220177481
    Abstract: The disclosure is directed to compounds of Formula I Pharmaceutical compositions comprising compounds of Formula I, as well as methods of their use and preparation, are also described.
    Type: Application
    Filed: February 17, 2022
    Publication date: June 9, 2022
    Inventors: Juan Luengo, Hong Lin, Michael Hawkins, Rupa Shetty, Philip Pitis, Gisela Saborit Villarroya
  • Publication number: 20220152073
    Abstract: The disclosure is directed to methods of treatment using compounds of Formula (I).
    Type: Application
    Filed: April 3, 2020
    Publication date: May 19, 2022
    Inventors: Hong Lin, Juan Luengo, Rupa Shetty, Michael Hawkins, Philip Pitis, Gisela Saborit Villarroya
  • Publication number: 20220153747
    Abstract: The disclosure is directed to compounds of Formula I Pharmaceutical compositions comprising compounds of Formula I, as well as methods of their use and preparation, are also described.
    Type: Application
    Filed: November 18, 2021
    Publication date: May 19, 2022
    Inventors: Hong Lin, Juan Luengo, Rupa Shetty, Michael Hawkins
  • Publication number: 20220152072
    Abstract: The disclosure is directed to methods of treating disease using compounds of Formula (I).
    Type: Application
    Filed: April 3, 2020
    Publication date: May 19, 2022
    Inventors: Hong Lin, Juan Luengo, Rupa Shetty, Michael Hawkins
  • Publication number: 20220056025
    Abstract: This invention relates to novel methods to prepare substituted pyrido[2,3-d]pyrimidin-7(8H)-ones, and salts and stereoisomers thereof, as well as intermediates useful for the preparation of such compounds.
    Type: Application
    Filed: September 23, 2019
    Publication date: February 24, 2022
    Applicant: Pfizer Inc.
    Inventors: Adam Ross Brown, Jean-Nicolas Desrosiers, Shengquan Duan, Joel Michael Hawkins, Cheryl Myers Hayward, Mark Thomas Maloney, Sebastien Monfette, Hahdi Hakimioun Perfect, Daniel William Widlicka
  • Patent number: 11254683
    Abstract: The disclosure is directed to compounds of Formula I Pharmaceutical compositions comprising compounds of Formula I, as well as methods of their use and preparation, are also described.
    Type: Grant
    Filed: August 5, 2020
    Date of Patent: February 22, 2022
    Assignee: Prelude Therapeutics Incorporated
    Inventors: Juan Luengo, Hong Lin, Michael Hawkins, Rupa Shetty, Philip Pitis, Gisela Saborit Villarroya
  • Patent number: 11214574
    Abstract: The disclosure is directed to compounds of Formula I Pharmaceutical compositions comprising compounds of Formula I, as well as methods of their use and preparation, are also described.
    Type: Grant
    Filed: June 1, 2020
    Date of Patent: January 4, 2022
    Assignee: Prelude Therapeutics, Incorporated
    Inventors: Juan Luengo, Hong Lin, Michael Hawkins, Rupa Shetty, Philip Pitis, Gisela Saborit Villarroya
  • Patent number: 11208416
    Abstract: The disclosure is directed to compounds of Formula I Pharmaceutical compositions comprising compounds of Formula I, as well as methods of their use and preparation, are also described.
    Type: Grant
    Filed: August 5, 2020
    Date of Patent: December 28, 2021
    Assignee: Prelude Therapeutics Incorporated
    Inventors: Hong Lin, Juan Luengo, Rupa Shetty, Michael Hawkins
  • Patent number: 11169551
    Abstract: A system includes a first valve fluidly connected to a first vessel and a second valve fluidly connected to a second vessel. The first valve includes a body and a piston. The body includes first and second ports and a bore having a longitudinal axis. The first port is in communication with the bore and an interior of the first vessel. The second port is in communication with the bore, the second valve, and an atmosphere exterior to the first vessel. The piston is movable along the longitudinal axis of the bore. A first position of the piston blocks the first port; a second position of the piston allows fluid communication between the first and second ports. The first valve is configured so that fluid pressure from the second valve, communicating through the second port, urges the piston to the second position.
    Type: Grant
    Filed: February 2, 2021
    Date of Patent: November 9, 2021
    Assignee: HEXAGON TECHNOLOGY AS
    Inventors: Michael Hawkins, Chad Cederberg
  • Publication number: 20210315723
    Abstract: An orthopedic device comprises a frame assembly comprising a parallel frame member and a perpendicular frame member. Each of the parallel frame member and the perpendicular frame member are substantially elongate in shape, and each have a first end and a second end. The orthopedic device further comprises at least three primary extensions each having a mount end and a free end. The perpendicular frame member is coupled by the first end thereof to the parallel frame member along the length of the parallel frame member between the first end and the second end thereof. Each of the at least three primary extensions is adjustably disposed by the mount end thereof along the frame assembly.
    Type: Application
    Filed: April 13, 2021
    Publication date: October 14, 2021
    Inventor: Michael Hawkins
  • Patent number: 11106760
    Abstract: Enhanced metadata with optimized output. In an embodiment, a content object is received. First metadata to be associated with the content object is determined. At least one metadata field to be acquired is determined based on an association, within a stored knowledge structure, of the at least one metadata field with the first metadata. Second metadata to be associated with the content object is acquired based on the at least one metadata field. A metadata structure and markup format for the content object are determined. The metadata structure incorporates both the first metadata and the second metadata. The content object is output with the metadata structure and in the markup format.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: August 31, 2021
    Assignee: EINSTEIN INDUSTRIES, INC.
    Inventors: Robert Silkey, Ted Ricasa, Sergiy Zubatiy, Jeremy Michael Hawkins, Christopher Cherry
  • Patent number: 11078205
    Abstract: The disclosure is directed to compounds of Formula I Pharmaceutical compositions comprising compounds of Formula I, as well as methods of their use and preparation, are also described.
    Type: Grant
    Filed: January 16, 2020
    Date of Patent: August 3, 2021
    Assignee: Prelude Therapeutics, Incorporated
    Inventors: Hong Lin, Juan Luengo, Rupa Shetty, Michael Hawkins
  • Publication number: 20210157343
    Abstract: A system includes a first valve fluidly connected to a first vessel and a second valve fluidly connected to a second vessel. The first valve includes a body and a piston. The body includes first and second ports and a bore having a longitudinal axis. The first port is in communication with the bore and an interior of the first vessel. The second port is in communication with the bore, the second valve, and an atmosphere exterior to the first vessel. The piston is movable along the longitudinal axis of the bore. A first position of the piston blocks the first port; a second position of the piston allows fluid communication between the first and second ports. The first valve is configured so that fluid pressure from the second valve, communicating through the second port, urges the piston to the second position.
    Type: Application
    Filed: February 2, 2021
    Publication date: May 27, 2021
    Inventors: Michael Hawkins, Chad Cederberg
  • Patent number: 10949230
    Abstract: A device may be configured to enable a user to select a language, and may fulfill resource requests from applications by selecting, from among resources respectively associated with a language, a resource associated with the selected language of the user. However, this resource selection process may be inadequate if the user selects multiple languages; if a resource associated with the selected language of the user is unavailable, but resources associated with related languages are available; or if the user and/or the application specifies an ordering for the selection among the languages. Presented herein are techniques for performing the resource selection by, for respective languages selected by the user, calculating a weight representing a suitability of the language for the resource request; generating a selection order of the selected languages according to the weights; and selecting a resource based on the position of the associated language in the selection order.
    Type: Grant
    Filed: May 31, 2012
    Date of Patent: March 16, 2021
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Rylan Michael Hawkins, Eric Scott Albright, Nick Beal, Peter Geoffrey Constable, Wade H. Curtiss, Erik Fortune, Andrew Stuart Glass, Samuel Aaron Beard, Microsoft Technology Licensing